Octavio Espinoza - 01 Oct 2023 Form 4 Insider Report for LIGAND PHARMACEUTICALS INC (LGND)

Role
Chief Financial Officer
Signature
By: /s/ Andrew Reardon For: Octavio Espinoza
Issuer symbol
LGND
Transactions as of
01 Oct 2023
Net transactions value
-$20,732
Form type
4
Filing time
03 Oct 2023, 16:36:06 UTC
Previous filing
10 Jul 2023
Next filing
06 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LGND Common Stock Tax liability $20,732 -346 -1.4% $59.92 24,171 01 Oct 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of restricted stock units.